Page last updated: 2024-08-25

ailanthone and Urinary Bladder Neoplasms

ailanthone has been researched along with Urinary Bladder Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Barrera, G; Cucci, MA; Damia, G; Dianzani, C; Grattarola, M; Pizzimenti, S; Ricci, F; Roetto, A; Trotta, F1
Barrera, G; Cavalli, R; Cucci, MA; Daga, M; Dianzani, C; Ferrara, B; Grattarola, M; Pizzimenti, S; Scariot, V; Trotta, F1

Other Studies

2 other study(ies) available for ailanthone and Urinary Bladder Neoplasms

ArticleYear
Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism.
    Free radical biology & medicine, 2020, Volume: 150

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Female; Humans; Kelch-Like ECH-Associated Protein 1; NF-E2-Related Factor 2; Ovarian Neoplasms; Oxidative Stress; Quassins; Urinary Bladder Neoplasms

2020
Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Mar-15, Volume: 56

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Down-Regulation; Drug Resistance, Neoplasm; Humans; NF-E2-Related Factor 2; Phosphoproteins; Proto-Oncogene Proteins c-myc; Quassins; Transcription Factors; Urinary Bladder Neoplasms; YAP-Signaling Proteins

2019